Literature DB >> 12120695

Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis.

Z A Erkut1, E Endert, I Huitinga, D F Swaab.   

Abstract

Hypothalmo-pituitary-adrenal (HPA) axis activity is altered in patients with multiple sclerosis (MS), resulting in elevated basal levels and enhanced response of cortisol in stimulation tests. HPA axis hyperactivation in MS is thought to be the result of complex interactions of genetic, immunologic, and neuroendocrinological mechanisms. In order to investigate whether cytokine levels in the central nervous system are associated with the activation of the HPA axis in MS, we measured cortisol, interleukin (IL)-6, IL-10 and TNF-alpha levels in postmortem cerebrospinal fluid (CSF) of 18 patients with severe MS and 50 controls. We also investigated the cortisol and cytokine levels in the CSF of a group of MS patients and controls who died with sepsis, in order to see whether acute infectious situations affect the association between cortisol and cytokines. The cortisol levels in MS patients were increased by 80% in comparison to controls (p=0.008). There was no difference in IL-6 levels between the groups, while IL-10 and TNF-alpha levels of the majority of subjects were below detection limits. There was a positive correlation between cortisol and IL-6 only in control patients with sepsis (r=0.89, p=0.019), but not within the MS patents with sepsis or MS and control groups without sepsis. Cortisol levels in postmortem serum and CSF were highly correlated (r>0.78, p<0.001). We concluded that the basal level of cortisol is significantly increased in the CSF of MS patients and that IL-6 is not responsible for this rise. The relationship between cortisol and IL-6 in sepsis is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12120695     DOI: 10.1191/1352458502ms797oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

1.  Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.

Authors:  Martina Santarsieri; Christian Niyonkuru; Emily H McCullough; Julie A Dobos; C Edward Dixon; Sarah L Berga; Amy K Wagner
Journal:  J Neurotrauma       Date:  2014-02-06       Impact factor: 5.269

2.  Hair cortisol concentration, cognitive, behavioral, and motor impairment in multiple sclerosis.

Authors:  Gabriela Magalhães Pereira; Jefferson Becker; Nayron Medeiros Soares; Lucas Araújo de Azeredo; Rodrigo Grassi-Oliveira; Andreo Rysdyk; Rosa Maria Martins de Almeida
Journal:  J Neural Transm (Vienna)       Date:  2019-06-27       Impact factor: 3.575

3.  Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice.

Authors:  Ashok Jangra; Mohit Kwatra; Tavleen Singh; Rajat Pant; Pawan Kushwah; Yogita Sharma; Babita Saroha; Ashok Kumar Datusalia; Babul Kumar Bezbaruah
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

4.  Rare cause of natural death in forensic setting: hemophagocytic syndrome.

Authors:  B Ondruschka; J-O Habeck; C Hädrich; J Dreßler; R Bayer
Journal:  Int J Legal Med       Date:  2015-12-30       Impact factor: 2.791

Review 5.  Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis.

Authors:  Gerwyn Morris; Edna Maria Vissoci Reiche; Andrea Murru; André F Carvalho; Michael Maes; Michael Berk; Basant K Puri
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

Review 6.  An evaluation of the recognised systemic inflammatory biomarkers of chronic sub-optimal inflammation provides evidence for inflammageing (IFA) during multiple sclerosis (MS).

Authors:  Christopher Bolton
Journal:  Immun Ageing       Date:  2021-04-14       Impact factor: 6.400

7.  Identification of a benzamide derivative that inhibits stress-induced adrenal corticosteroid synthesis.

Authors:  Jing Xu; Laurent Lecanu; Matthew Tan; Janet Greeson; Vassilios Papadopoulos
Journal:  Molecules       Date:  2009-09-03       Impact factor: 4.411

Review 8.  Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations.

Authors:  Tamás Biernacki; Zsófia Kokas; Dániel Sandi; Judit Füvesi; Zsanett Fricska-Nagy; Péter Faragó; Tamás Zsigmond Kincses; Péter Klivényi; Krisztina Bencsik; László Vécsei
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.